World's Best Scientists 2026 revealed!
Christopher G. Willett

Christopher G. Willett

D-Index & Metrics

Medicine

D-Index
112
Citations
54398
World Ranking
5098
National Ranking
2758

Christopher G. Willett publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christopher G. Willett sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 545 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Christopher G. Willett D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher G. Willett sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 112 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Christopher G. Willett is affiliated with Duke University in the United States and has contributed extensively to the field of medicine, with a primary focus on oncology, surgery, pulmonary and respiratory medicine, radiology, and radiation. Their scholarly work encompasses 88 publications across these areas, reflecting deep engagement with both clinical and research aspects of cancer and related medical disciplines.

The scientist's research topics include:

  • Gastric Cancer Management and Outcomes
  • Colorectal and Anal Carcinomas
  • Colorectal Cancer Surgical Treatments
  • Advanced Radiotherapy Techniques
  • Colorectal Cancer Treatments and Studies
  • Esophageal Cancer Research and Treatment
  • Genetic factors in colorectal cancer

Recent papers by Christopher G. Willett highlight involvement in clinical practice guidelines for oncology, published primarily in the Journal of the National Comprehensive Cancer Network. These include:

  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology (2021), Journal of the National Comprehensive Cancer Network
  • Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology (2022), Journal of the National Comprehensive Cancer Network
  • Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology (2022), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Rectal Cancer, Version 6.2020 (2020), Journal of the National Comprehensive Cancer Network
  • Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology (2023), Journal of the National Comprehensive Cancer Network

Their work has been frequently published in the following venues:

  • Journal of the National Comprehensive Cancer Network (12 publications)
  • International Journal of Radiation Oncology*Biology*Physics (8 publications)
  • Journal of Clinical Oncology (3 publications)
  • Holland-Frei Cancer Medicine (2 publications)
  • Cancer (2 publications)

In collaboration, Christopher G. Willett has frequently co-authored with:

  • Brian G. Czito (17 joint publications)
  • Manisha Palta (16 joint publications)
  • Qiuwen Wu (11 joint publications)
  • Mary F. Mulcahy (9 joint publications)
  • F Yin (8 joint publications)

This record reflects a sustained research focus on improving knowledge and practice surrounding gastrointestinal cancers, particularly colorectal, gastric, and esophageal cancers, utilizing both surgical and radiotherapeutic approaches. Their contributions to clinical guidelines support the translation of research insights into clinical oncology practices.

Best Publications

  • Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Christopher G Willett;Yves Boucher;Emmanuelle di Tomaso;Dan G Duda

  • Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

    Carolyn C. Compton;L. Peter Fielding;Lawrence J. Burgart;Barbara Conley

  • Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

    Joel Tepper;Mark J. Krasna;Donna Niedzwiecki;Donna Hollis

  • Prognostic Factors in Colorectal Cancer

    Carolyn C. Compton;Carolyn C. Compton;L. Peter Fielding;Lawrence J. Burgart;Barbara Conley

  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

    Al B. Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Mustafa A. Arain

  • Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

    Al B. Benson;Alan P. Venook;Lynette Cederquist;Emily Chan

  • NCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines

    Al B Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Lynette Cederquist

  • Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

    William F. Regine;Kathryn A. Winter;Ross A. Abrams;Howard Safran

  • Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal: A Randomized Controlled Trial

    Jaffer A. Ajani;Kathryn A. Winter;Leonard L. Gunderson;John Pedersen

  • Differentiating the pathologies of cerebral malaria by postmortem parasite counts.

    Terrie E Taylor;Wenjiang J Fu;Wenjiang J Fu;Richard A Carr;Richard O Whitten

  • Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

    Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem

  • Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

    Jaffer A. Ajani;Thomas A. D'Amico;David J. Bentrem;Joseph Chao

  • Rectal cancer, version 2.2018 clinical practice guidelines in Oncology

    Al B Benson;Alan P. Venook;Mahmoud M. Al-Hawary;Lynette Cederquist

  • NCCN Clinical Practice Guidelines in Oncology: colon cancer.

    Engstrom Pf;Arnoletti Jp;Benson Ab rd;Chen Yj

  • RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.

    Lisa A. Kachnic;Kathryn Winter;Robert J. Myerson;Michael D. Goodyear

  • Long-term results of RTOG trial 8911 (USA intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

    David P. Kelsen;Katryn A. Winter;Leonard L. Gunderson;Joanne Mortimer

  • Biomarkers of response and resistance to antiangiogenic therapy.

    Rakesh K. Jain;Dan G. Duda;Christopher G. Willett;Dushyant V. Sahani

  • Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

    Leonard L. Gunderson;Kathryn A. Winter;Jaffer A. Ajani;John E. Pedersen

  • Gastric Cancer, Version 2.2013

    Jaffer A. Ajani;David J. Bentrem;Stephen Besh;Thomas A. D'Amico

  • Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012. (5)

    Christopher G. Willett;Daniel T. Chang;Brian G. Czito;Jeffrey J Meyer

Frequent Co-Authors

David P. Ryan
David P. Ryan Harvard University
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Rakesh K. Jain
Rakesh K. Jain Harvard University
Al B. Benson
Al B. Benson Northwestern University
Dan G. Duda
Dan G. Duda Harvard University
Joel E. Tepper
Joel E. Tepper University of North Carolina at Chapel Hill
Mary F. Mulcahy
Mary F. Mulcahy Northwestern University
Johanna C. Bendell
Johanna C. Bendell Sarah Cannon Research Institute
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Many students interested in studying Medicine in the USA also consider various online degrees and certifications to expand their career options. Whether you aim to start quickly or advance professionally, there are numerous online pathways to explore.

For registered nurses seeking to advance rapidly, the cheapest online dnp programs make earning a Doctor of Nursing Practice more accessible and affordable. Those new to healthcare might consider online lpn programs, which are designed for quick entry into the nursing workforce.

Mental health is a fast-growing field. Nurses with a master’s degree can complete licensure requirements faster through the shortest post master's pmhnp online programs, opening opportunities in psychiatric and mental health practice. Aspiring healthcare leaders may pursue an online health management degree to develop administrative expertise in hospitals or clinics.

These diverse programs offer flexible, affordable ways to achieve your healthcare career goals alongside or in place of traditional U.S. medical education pathways.

Best Scientists Citing Christopher G. Willett

Trending Scientists

Recently Published Articles